{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:08:34Z","timestamp":1783397314856,"version":"3.54.6"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Fatal heroin overdose is a significant cause of mortality for injection drug users (IDUs). Many of these deaths are preventable because opiate overdoses can be quickly and safely reversed through the injection of Naloxone [brand name Narcan], a prescription drug used to revive persons who have overdosed on heroin or other opioids. Currently, in several cities in the United States, drug users are being trained in naloxone administration and given naloxone for immediate and successful reversals of opiate overdoses. There has been very little formal description of the challenges faced in the development and implementation of large-scale IDU naloxone administration training and distribution programs and the lessons learned during this process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>During a one year period, over 1,000 participants were trained in SKOOP (Skills and Knowledge on Opiate Prevention) and received a prescription for naloxone by a medical doctor on site at a syringe exchange program (SEP) in New York City. Participants in SKOOP were over the age of 18, current participants of SEPs, and current or former drug users. We present details about program design and lessons learned during the development and implementation of SKOOP. Lessons learned described in the manuscript are collectively articulated by the evaluators and implementers of the project.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There were six primary challenges and lessons learned in developing, implementing, and evaluating SKOOP. These include a) political climate surrounding naloxone distribution; b) extant prescription drug laws; c) initial low levels of recruitment into the program; d) development of participant appropriate training methodology; e) challenges in the design of a suitable formal evaluation; and f) evolution of program response to naloxone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Other naloxone distribution programs may anticipate similar challenges to SKOOP and we identify mechanisms to address them. Strategies include being flexible in program planning and implementation, developing evaluation instruments for feasibility and simplicity, and responding to and incorporating feedback from participants.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7517-4-3","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T19:12:38Z","timestamp":1169752358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City"],"prefix":"10.1186","volume":"4","author":[{"given":"Tinka Markham","family":"Piper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Rudenstine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Stancliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Clear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Galea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,25]]},"reference":[{"key":"76_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.7326\/0003-4819-130-7-199904060-00019","volume":"130","author":"KA Sporer","year":"1999","unstructured":"Sporer KA: Acute heroin overdose. Ann Intern Med. 1999, 130: 584-590.","journal-title":"Ann Intern Med"},{"key":"76_CR2","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/j.1360-0443.1996.tb03800.x","volume":"91","author":"S Darke","year":"1996","unstructured":"Darke S, Zador D: Fatal heroin \"overdose\": a review. Addiction. 1996, 91: 1765-1772. 10.1111\/j.1360-0443.1996.tb03800.x.","journal-title":"Addiction"},{"key":"76_CR3","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1046\/j.1360-0443.2002.00210.x","volume":"97","author":"PJ Davidson","year":"2002","unstructured":"Davidson PJ, Ochoa KC, Hahn JA, Evans JL, Moss AR: Witnessing heroin-related overdoses: The experiences of young injectors in San Francisco. Addiction. 2002, 97: 1511-1516. 10.1046\/j.1360-0443.2002.00210.x.","journal-title":"Addiction"},{"key":"76_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0306-4603(00)00115-5","volume":"26","author":"KC Ochoa","year":"2001","unstructured":"Ochoa KC, Hahn JA, Seal KH, Moss AR: Overdosing among young injection drug users in San Francisco. Addict Behav. 2001, 26: 453-460. 10.1016\/S0306-4603(00)00115-5.","journal-title":"Addict Behav"},{"issue":"11","key":"76_CR5","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.2105\/AJPH.91.11.1842","volume":"91","author":"KH Seal","year":"2001","unstructured":"Seal KH, Kral AH, Gee L, Moore LD, Bluthenthal RL, Lorvick J, Edlin BR: Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998\u20131999. Am J Public Health. 2001, 91 (11): 1842-6.","journal-title":"Am J Public Health"},{"key":"76_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1046\/j.1360-0443.2003.00376.x","volume":"98","author":"PO Coffin","year":"2003","unstructured":"Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K: Opiates, cocaine and alcohol combinations in drug overdose deaths in new York City, 1990\u20131998. Addiction. 2003, 98: 739-47. 10.1046\/j.1360-0443.2003.00376.x.","journal-title":"Addiction"},{"key":"76_CR7","volume-title":"Office of Vital Statistics, New York","author":"New York City Department of Health and Mental Hygiene (NYC DOHMH)","year":"2003","unstructured":"New York City Department of Health and Mental Hygiene (NYC DOHMH): Summary of vital statistics 2002: The City of New York. Office of Vital Statistics, New York. 2003, [http:\/\/www.nyc.gov\/html\/doh\/downloads\/pdf\/vs\/2002sum.pdf]"},{"key":"76_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1360-0443.1999.9421993.x","volume":"94","author":"J Strang","year":"1999","unstructured":"Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, Welch S, Gossop M: Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction. 1999, 94: 199-204. 10.1046\/j.1360-0443.1999.9421993.x.","journal-title":"Addiction"},{"key":"76_CR9","unstructured":"Bigg D, Maxwell S: Enabling people to stay alive: an effective opiate overdose prevention program. Paper presented at The Fourth National Harm Reduction Conference. Seattle, WA. December 2, 2002"},{"key":"76_CR10","unstructured":"Drug Overdose Prevention and Education (DOPE) Project. San Francisco, California. [http:\/\/www.thedopeproject.org\/]"},{"issue":"5","key":"76_CR11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.addbeh.2005.07.020","volume":"31","author":"S Galea","year":"2006","unstructured":"Galea S, Worthington N, Markham Piper T, Nandi VV, Curtis M, Rosenthal D: Provision of naloxone to injection drug users as an overdose prevention strategy: Early evidence from a pilot study in New York City. Addict Behav. 2006, 31 (5): 907-12. 10.1016\/j.addbeh.2005.07.020.","journal-title":"Addict Behav"},{"key":"76_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jurban\/jti053","volume":"82","author":"KH Seal","year":"2005","unstructured":"Seal KH, Thawley R, Gee L, Bamburger J, Kral AH, Ciccarone D, Downing M, Edlin BR: Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. J Urban Health. 2005, 82: 303-311.","journal-title":"J Urban Health"},{"key":"76_CR13","unstructured":"Sherman SG, Tobin K, Rucker M, Latkin CA: A description of the Baltimore city overdose prevention program: Staying Alive. Paper presented at the 15th International Harm Reduction Conference. Belfast,Ireland. March 13, 2005"},{"key":"76_CR14","volume-title":"Manuscript under review","author":"SG Sherman","year":"2006","unstructured":"Sherman SG, Cheng Y, Kral AH: Prevalence and correlates of opiate overdose among young injection drug users in Baltimore, Maryland. Manuscript under review. 2006"},{"key":"76_CR15","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1111\/j.1360-0443.2005.01259.x","volume":"100","author":"CT Baca","year":"2005","unstructured":"Baca CT, Grant KJ: Take-home naloxone to reduce heroin death. Addiction. 2005, 100: 1823-1831. 10.1111\/j.1360-0443.2005.01259.x.","journal-title":"Addiction"},{"key":"76_CR16","unstructured":"Harm Reduction Coalition. [http:\/\/www.harmreduction.org\/index.html]"},{"key":"76_CR17","unstructured":"Chicago Recovery Alliance: Opiate OD prevention\/intervention work in Chicago. [http:\/\/www.anypositivechange.org\/OD1202.pdf]"},{"key":"76_CR18","first-page":"813","volume":"37","author":"S Burris","year":"2003","unstructured":"Burris S, Strathdee SA, Vernick JS: Lethal injections: The law, science and politics of syringe access for injection drug users. Univ San Francisco Law Rev. 2003, 37: 813-885.","journal-title":"Univ San Francisco Law Rev"},{"key":"76_CR19","unstructured":"New York State Department of Health: Opioid Overdose Prevention Program Emergency Regulations. [http:\/\/www.health.state.ny.us\/diseases\/aids\/harm_reduction\/opioidprevention\/regulations.htm]"},{"key":"76_CR20","unstructured":"Stancliff S: Personal communication. July 27, 2006"},{"key":"76_CR21","unstructured":"Sporer KA, Kral AH: Prescription naloxone: A novel approach to heroin overdose prevention. Ann Emerg Med."},{"key":"76_CR22","unstructured":"Kinzly M: Personal communication. July 27, 2006"},{"key":"76_CR23","unstructured":"Fuller C, C\u00e1ceres W, Standish K, Lewis E, Rudolph A, Vlahov D: Using pharmacists to link injection drug users to medical and social services in New York City. Poster to be presented at the 6th Annual International Conference on Urban Health. Amsterdam, the Netherlands. October 25\u201328, 2006"},{"issue":"1","key":"76_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-7517-3-19","volume":"3","author":"N Worthington","year":"2006","unstructured":"Worthington N, Markham Piper T, Rosenthal D, Galea S: Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study. Harm Reduct J. 2006, 3 (1): 19-","journal-title":"Harm Reduct J"},{"issue":"3","key":"76_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1300\/J069v25n03_11","volume":"25","author":"S Maxwell","year":"2006","unstructured":"Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S: Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006, 25 (3): 89-96.","journal-title":"J Addict Dis"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7517-4-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:07:02Z","timestamp":1630454822000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/1477-7517-4-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1186\/1477-7517-4-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,25]]},"assertion":[{"value":"22 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"3"}}